The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells
Authors
Keywords
-
Journal
CARCINOGENESIS
Volume 32, Issue 4, Pages 488-495
Publisher
Oxford University Press (OUP)
Online
2011-01-25
DOI
10.1093/carcin/bgr007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pim-1 Kinase Expression Predicts Radiation Response in Squamocellular Carcinoma of Head and Neck and Is under the Control of Epidermal Growth Factor Receptor
- (2015) Katriina Peltola et al. NEOPLASIA
- Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma
- (2010) Carolin Reiser-Erkan et al. CANCER BIOLOGY & THERAPY
- PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers
- (2010) L. Brault et al. HAEMATOLOGICA
- Ras-Related Small GTPases RalA and RalB Regulate Cellular Survival After Ionizing Radiation
- (2010) Ambrose R. Kidd et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hypoxia-Mediated Up-Regulation of Pim-1 Contributes to Solid Tumor Formation
- (2009) Jian Chen et al. AMERICAN JOURNAL OF PATHOLOGY
- Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells
- (2009) L. S. Chen et al. BLOOD
- A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell Survival
- (2009) Anurag Singh et al. CANCER CELL
- Dissection of PIM serine/threonine kinases in FLT3-ITD–induced leukemogenesis reveals PIM1 as regulator of CXCL12–CXCR4-mediated homing and migration
- (2009) Rebekka Grundler et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Characterization of Novel Diaryl Oxazole-Based Compounds as Potential Agents to Treat Pancreatic Cancer
- (2009) A. Y. Shaw et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes
- (2009) S. M. Mumenthaler et al. MOLECULAR CANCER THERAPEUTICS
- Consensus transcriptome signature of perineural invasion in pancreatic carcinoma
- (2009) I. Abiatari et al. MOLECULAR CANCER THERAPEUTICS
- Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells
- (2009) Z. Beharry et al. MOLECULAR CANCER THERAPEUTICS
- Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes
- (2009) Chunaram Choudhary et al. MOLECULAR CELL
- Pim-1 plays a pivotal role in hypoxia-induced chemoresistance
- (2009) J Chen et al. ONCOGENE
- Pim Kinases Promote Cell Cycle Progression by Phosphorylating and Down-regulating p27Kip1 at the Transcriptional and Posttranscriptional Levels
- (2008) D. Morishita et al. CANCER RESEARCH
- Potential roles for the PIM1 kinase in human cancer – A molecular and therapeutic appraisal
- (2008) Nilesh Shah et al. EUROPEAN JOURNAL OF CANCER
- Synthesis and Evaluation of Novel Inhibitors of Pim-1 and Pim-2 Protein Kinases
- (2008) Zuping Xia et al. JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started